(Q58388947)
Statements
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy (English)
Jean-Michel Molina
Constance Delaugerre
Juliette Pavie
Carlo Torti
José Medrano
Nadia Valin
Jade Ghosn
NEAT Unboosted Atazanavir Cohort Study Group